
European Commission approval for Dzuveo
AcelRx’ Dzuveo has won approval in the European Union for the management of acute moderate to severe pain in medically monitored settings.Dzuveo is a sublingual tablet formulation of the opioid analgesic sufentanil, designed to address […]